Holen Sie sich die Stockscreener-App
29.71
0.88%
-0.263
Finanzdaten der Second Sight Medical Products,-Aktie (EYES)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
0.84%
6.874
|
6.817 | 6.81 | 6.725 | 7.462 |
| Operating Income/Loss |
0.84%
-6.874
|
-6.817 | -6.81 | -6.725 | -7.462 |
| Net Income/Loss |
6.05%
-6.37
|
-6.78 | -6.633 | -6.53 | -7.144 |
| Basic Average Shares |
7.16%
87.09
|
81.27 | - | 59.71 | 59.24 |
| Diluted Average Shares |
7.16%
87.09
|
81.27 | - | 59.71 | 59.24 |
| Basic Earnings Per Share |
12.50%
-0.07
|
-0.08 | - | -0.11 | -0.12 |
| Diluted Earnings Per Share |
12.50%
-0.07
|
-0.08 | - | -0.11 | -0.12 |
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):